Drugs / natural killer cell infusion
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01857934 | Jul 2013 → Oct 2021 | neuroblastoma | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | natural killer cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01857934 ↗ |
| Modality | Cell therapy | “Natural killer (NK) cells obtained from a suitable donor will be given together with hu14.18K322A” NCT01857934 ↗ |